首页>
外国专利>
USE OF 7-(2-OXA-5,8-DIAZABICYCLO 4,3,0 NON-8-YL)-QUINOLONECARBOXYLIC ACID AND NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVES FOR THE THERAPY OF HELICOBACTER PYLORI INFECTIONS AND THE GASTRODUODENAL DISORDERS ASSOCIATED THEREWITH
USE OF 7-(2-OXA-5,8-DIAZABICYCLO 4,3,0 NON-8-YL)-QUINOLONECARBOXYLIC ACID AND NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVES FOR THE THERAPY OF HELICOBACTER PYLORI INFECTIONS AND THE GASTRODUODENAL DISORDERS ASSOCIATED THEREWITH
PCT No. PCT/EP97/06781 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Dec. 4, 1997 PCT Pub. No. WO98/26779 PCT Pub. Date Jun. 25, 1998The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.
展开▼